Bausch + Lomb Corporation

BLCO ·Healthcare, Medical Devices, Ontario, Canada
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Operating Activities
Net Income $-360.0M $-317.0M $-260.0M $6.0M $182.0M $-18.0M
Depreciation & Amortization $421.0M $436.0M $382.0M $379.0M $415.0M $442.0M
Depreciation $163.0M $148.0M $142.0M $135.0M $123.0M $119.0M
Amortization — — — — — —
Stock-Based Compensation $149.0M $92.0M $74.0M $62.0M $62.0M $50.0M
Net Cash from Operating Activities $283.0M $232.0M $-17.0M $345.0M $873.0M $522.0M
Investing Activities
Capital Expenditures $349.0M $291.0M $181.0M $175.0M $193.0M $253.0M
Business Acquisitions — — — — — —
Net Cash from Investing Activities $-455.0M $-412.0M $-2.11B $-215.0M $-214.0M $-256.0M
Financing Activities
Dividends Paid — — — — — —
Stock Repurchases — — — — — —
Net Cash from Financing Activities $225.0M $178.0M $2.08B $81.0M $-712.0M $-232.0M
Net Change in Cash $81.0M $-18.0M $-46.0M $203.0M $-61.0M $46.0M
Free Cash Flow $-66.0M $-59.0M $-198.0M $170.0M $680.0M $269.0M